Emmaus Life Sciences Competitors and Similar CompaniesClear all
Emmaus Life Sciences's competitors and similar companies include Omega Therapeutics, CRISPR Therapeutics, LogicBio Therapeutics and Ichor Life Sciences.
 Emmaus Life Sciences Emmaus Life Sciences is a biopharmaceutical company that provides treatments and therapies for rare and orphan diseases. |  CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases. |  LogicBio Therapeutics LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment. |  Ichor Life Sciences Ichor Life Sciences (formerly known as Ichor Therapeutics) is a biopharmaceutical company that develops drugs with a focus on the illnesses of aging. | ||
Founding Date | Founding Date 2000 | Founding Date 2017 | Founding Date 2013 | Founding Date 2014 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Torrance, US HQ | Locations Cambridge, US HQ | Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US | Locations Lexington, US HQ Louisville, US | Locations Syracuse, US HQ La Fayette, US |
Employees | Employees 21 | Employees 60 | Employees 393 | Employees 4178% increase | Employees 37 |
Valuation ($) | Valuation ($) 2.4 m | Valuation ($) 68.4 m | Valuation ($) 4.2 b | Valuation ($) 176.3 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $12.5m (FY, 2025) | Revenue (est.) $3.1m (FY, 2023) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) $5.4m (FY, 2021) | Revenue (est.) N/A |
Net income | Net income ($7.5m) (FY, 2025) | Net income ($97.4m) (FY, 2023) | Net income ($581.6m) (FY, 2025) | Net income ($40m) (FY, 2021) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 21m | Total funding raised $ 211m | Total funding raised $ 127m | Total funding raised $ 49m | Total funding raised $ 4.5m |
For sources of this data, please see the company profile
View Company Profiles
Omega Therapeutics
HQ
Cambridge, US
Employees
60
Omega Therapeutics is an epigenomic medicine company.
View companyCRISPR Therapeutics
HQ
Zug, CH
Employees
393
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
View companyLogicBio Therapeutics
HQ
Lexington, US
Employees
41
LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment.
View companyIchor Life Sciences
HQ
Syracuse, US
Employees
37
Ichor Life Sciences (formerly known as Ichor Therapeutics) is a biopharmaceutical company that develops drugs with a focus on the illnesses of aging.
View company